volume 5, issue 7, P539-550 2013
DOI: 10.18632/aging.100576
View full text
Has erratum 2020-4-8
|
|
Share

Abstract: Rapamycin extends lifespan in mice, but can have a number of undesirable effects that may ultimately limit its utility in humans. The canonical target of rapamycin, and the one thought to account for its effects on lifespan, is the mammalian/mechanistic target of rapamycin, complex 1 (mTORC1). We have previously shown that at least some of the detrimental side effects of rapamycin are due to “off target” disruption of mTORC2, suggesting they could be avoided by more specific targeting of mTORC1. However, mTORC…

Expand abstract
Editorial notices

Search citation statements

Order By: Relevance

Paper Sections

0
0
0
0
0

Citation Types

2
20
0

Publication Types

0
0
0
0

Relationship

0
0

Authors

Journals